Skip to main content

Corporate insider profile

Mark Hopman Insider Trades

Latest reported as Chief Commercial Officer of Beta Bionics, Inc. (BBNX).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,540,537.05
Latest transaction
Oct 26, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 26, 2026Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSale821$20.00$16,420
Oct 14, 2026Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSale775$17.35$13,446
Oct 1, 2026Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSale370$18.96$7,015
Sep 16, 2026Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSale30,779$20.13$619,640
Sep 14, 2026Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSale775$15.52$12,028
Sep 9, 2026Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSale36,870$18.46$680,723
Sep 2, 2026Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSale5,327$19.11$101,815
Jun 24, 2026Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSale1,258$15.01$18,880
Jun 4, 2026Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSale275$12.31$3,385
Jun 2, 2026Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSale5,329$12.61$67,183